4//SEC Filing
Furlong Tammy 4
Accession 0001415889-25-013621
CIK 0001783032other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:15 PM ET
Size
11.2 KB
Accession
0001415889-25-013621
Insider Transaction Report
Form 4
Furlong Tammy
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-05-15−300→ 2,100 total→ Common Stock (300 underlying) - Tax Payment
Common Stock
2025-05-15$0.30/sh−784$235→ 10,075 total - Exercise/Conversion
Restricted Stock Unit
2025-05-15−2,343→ 25,782 total→ Common Stock (2,343 underlying) - Exercise/Conversion
Common Stock
2025-05-15+2,643→ 10,859 total
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]25% of the RSUs vested on February 15, 2025, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F3]The RSUs do not expire; they either vest or are canceled prior to the vesting date.
- [F4]25% of the RSUs vested on February 15, 2024, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Documents
Issuer
Elevation Oncology, Inc.
CIK 0001783032
Entity typeother
Related Parties
1- filerCIK 0001984204
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:15 PM ET
- Size
- 11.2 KB